in vivo first [Software]

posted by jag009  – NJ, 2012-10-04 18:10 (5006 d 01:43 ago) – Posting: # 9309
Views: 9,638

(edited on 2012-10-04 20:09)

Hi Sam,

Don't bother with how Pharsight selects CR01, CR02, CR03, CR04 for their IVIVC example... It is just an example. Target formulation is your target formulation, you know... Formulation which is bioequivalent to the reference (for ANDA).

In short, internal validation means to determine the predictability of the IVIVC model by testing it with data that was used in its development: The Fast, Medium, slow formulation data.

External validation means you use data from a formulation which is not involved in developing the IVIVC model to test the IVIVC model for its predictability.

In both validation, the predictability is to compare the IVIVC predicted in-vivo profile to the observed (real data) in-vivo profile. Comparison is based on AUC and Cmax. Refer to FDA guidance for predictability formula and criteria.

See if you can get access to a book "In-vitro In-vivo correlatons" written by Young, Devane and Butler. Read that book and you will have all your answers.

Almost forgot, Pharsight gives online webinar demonstration of their IVIVC software. Contact Pharsight for their next demo and you will get most of your answers there.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
176 visitors (0 registered, 176 guests [including 21 identified bots]).
Forum time: 19:54 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5